NCT02864030 2021-03-04
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
Oncologia Medica dell'Ospedale Fatebenefratelli
Phase 4 Completed
Oncologia Medica dell'Ospedale Fatebenefratelli
HealthPartners Institute
National Cancer Institute (NCI)